139 related articles for article (PubMed ID: 35679759)
1. Generation and characterisation of four multiple sclerosis iPSC lines from a single family.
Fortune AJ; Taylor BV; Charlesworth JC; Burdon KP; Blackburn NB; Fletcher JL; Mehta A; Young KM
Stem Cell Res; 2022 Jul; 62():102828. PubMed ID: 35679759
[TBL] [Abstract][Full Text] [Related]
2. Generation of six multiple sclerosis patient-derived induced pluripotent stem cell lines.
Miquel-Serra L; Duarri A; Muñoz Y; Kuebler B; Aran B; Costa C; Martí M; Comabella M; Malhotra S; Montalban X; Veiga A; Raya A
Stem Cell Res; 2017 Oct; 24():155-159. PubMed ID: 29034884
[TBL] [Abstract][Full Text] [Related]
3. Generation of RRMS and PPMS specific iPSCs as a platform for modeling Multiple Sclerosis.
Mutukula N; Man Z; Takahashi Y; Iniesta Martinez F; Morales M; Carreon-Guarnizo E; Hernandez Clares R; Garcia-Bernal D; Martinez Martinez L; Lajara J; Nuñez Delicado E; Meca Lallana JE; Izpisua Belmonte JC
Stem Cell Res; 2021 May; 53():102319. PubMed ID: 33894548
[TBL] [Abstract][Full Text] [Related]
4. Using MS induced pluripotent stem cells to investigate MS aetiology.
Fortune AJ; Fletcher JL; Blackburn NB; Young KM
Mult Scler Relat Disord; 2022 Jul; 63():103839. PubMed ID: 35523059
[TBL] [Abstract][Full Text] [Related]
5. Generation and characterization of human induced pluripotent stem cell line METUi001-A from a 25-year-old male patient with relapsing-remitting multiple sclerosis.
Begentas OC; Koc D; Yurtogullari S; Temel M; Akcali KC; Demirkaya S; Kiris E
Stem Cell Res; 2021 May; 53():102370. PubMed ID: 34087999
[TBL] [Abstract][Full Text] [Related]
6. Generation of MNZTASi001-A, a human pluripotent stem cell line from a person with primary progressive multiple sclerosis.
Mehta A; Lu P; Taylor BV; Charlesworth J; Cook AL; Burdon KP; Hewitt AW; Young KM
Stem Cell Res; 2021 Dec; 57():102568. PubMed ID: 34678664
[TBL] [Abstract][Full Text] [Related]
7. Induced Stem Cells as a Novel Multiple Sclerosis Therapy.
Xie C; Liu YQ; Guan YT; Zhang GX
Curr Stem Cell Res Ther; 2016; 11(4):313-20. PubMed ID: 25732737
[TBL] [Abstract][Full Text] [Related]
8. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Liu Y; Deng W
Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
[TBL] [Abstract][Full Text] [Related]
9. Treatment of multiple sclerosis by transplantation of neural stem cells derived from induced pluripotent stem cells.
Zhang C; Cao J; Li X; Xu H; Wang W; Wang L; Zhao X; Li W; Jiao J; Hu B; Zhou Q; Zhao T
Sci China Life Sci; 2016 Sep; 59(9):950-7. PubMed ID: 27233903
[TBL] [Abstract][Full Text] [Related]
10. Copy number variant hotspots in Han Taiwanese population induced pluripotent stem cell lines - lessons from establishing the Taiwan human disease iPSC Consortium Bank.
Huang CY; Li LH; Hsu WT; Cheng YC; Nicholson MW; Liu CL; Ting CY; Ko HW; Syu SH; Wen CH; Yan Z; Huang HP; Su HL; Chiang PM; Shen CN; Chen HF; Yen BLJ; Lu HE; Hwang SM; Chiou SH; Ho HN; Wu JY; Kamp TJ; Wu JC; Hsieh PCH
J Biomed Sci; 2020 Sep; 27(1):92. PubMed ID: 32887585
[TBL] [Abstract][Full Text] [Related]
11. Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette.
Somers A; Jean JC; Sommer CA; Omari A; Ford CC; Mills JA; Ying L; Sommer AG; Jean JM; Smith BW; Lafyatis R; Demierre MF; Weiss DJ; French DL; Gadue P; Murphy GJ; Mostoslavsky G; Kotton DN
Stem Cells; 2010 Oct; 28(10):1728-40. PubMed ID: 20715179
[TBL] [Abstract][Full Text] [Related]
12. Modelling multiple sclerosis using induced pluripotent stem cells.
Martínez-Larrosa J; Matute-Blanch C; Montalban X; Comabella M
J Neuroimmunol; 2020 Dec; 349():577425. PubMed ID: 33130461
[TBL] [Abstract][Full Text] [Related]
13. Effects of Integrating and Non-Integrating Reprogramming Methods on Copy Number Variation and Genomic Stability of Human Induced Pluripotent Stem Cells.
Kang X; Yu Q; Huang Y; Song B; Chen Y; Gao X; He W; Sun X; Fan Y
PLoS One; 2015; 10(7):e0131128. PubMed ID: 26131765
[TBL] [Abstract][Full Text] [Related]
14. Generation of four patient-specific pluripotent induced stem cell lines from two Brazilian patients with amyotrophic lateral sclerosis and two healthy subjects.
Gubert F; Vasques JF; Cozendey TD; Domizi P; Toledo MF; Kasai-Brunswick TH; Loureiro MPS; Lima JMB; Gress CH; Cabello GMK; Cabello PH; Borgonovo T; Vaz IM; Silva R; Mendez-Otero R
Stem Cell Res; 2019 May; 37():101448. PubMed ID: 31077962
[TBL] [Abstract][Full Text] [Related]
15. Generation of neural cells from DM1 induced pluripotent stem cells as cellular model for the study of central nervous system neuropathogenesis.
Xia G; Santostefano KE; Goodwin M; Liu J; Subramony SH; Swanson MS; Terada N; Ashizawa T
Cell Reprogram; 2013 Apr; 15(2):166-77. PubMed ID: 23550732
[TBL] [Abstract][Full Text] [Related]
16. Inflammation and degeneration in multiple sclerosis.
Brück W; Stadelmann C
Neurol Sci; 2003 Dec; 24 Suppl 5():S265-7. PubMed ID: 14652785
[TBL] [Abstract][Full Text] [Related]
17. A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells.
Burkhardt MF; Martinez FJ; Wright S; Ramos C; Volfson D; Mason M; Garnes J; Dang V; Lievers J; Shoukat-Mumtaz U; Martinez R; Gai H; Blake R; Vaisberg E; Grskovic M; Johnson C; Irion S; Bright J; Cooper B; Nguyen L; Griswold-Prenner I; Javaherian A
Mol Cell Neurosci; 2013 Sep; 56():355-64. PubMed ID: 23891805
[TBL] [Abstract][Full Text] [Related]
18. Generation of two additional integration-free iPSC lines from related human donors.
Ramme AP; Faust D; Koenig L; Nguyen N; Marx U
Stem Cell Res; 2021 May; 53():102327. PubMed ID: 33901815
[TBL] [Abstract][Full Text] [Related]
19. Mitoxantrone in relapsing-remitting and rapidly progressive multiple sclerosis: Ten-year clinical outcomes post-treatment with mitoxantrone.
Foo EC; Russell M; Lily O; Ford HL
Mult Scler Relat Disord; 2020 Sep; 44():102330. PubMed ID: 32599468
[TBL] [Abstract][Full Text] [Related]
20. Generation of six induced pluripotent stem cell (iPSC) lines from two patients with amyotrophic lateral sclerosis (NUIGi043-A, NUIGi043-B, NUIGi043-C, NUIGi044-A, NUIGi044-B, NUIGi044-C).
Yang M; Liu M; Vajda A; O'Brien T; Henshall D; Hardiman O; Shen S
Stem Cell Res; 2019 Oct; 40():101558. PubMed ID: 31514057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
